Literature DB >> 12221866

Angioedema. Pathogenesis, differential diagnosis, and treatment.

Evangelo Frigas1, Ugochukwu C Nzeako.   

Abstract

Angioedema is a constellation of syndromes that present a great challenge to the clinician. The term "angioedema" describes the localized, transient, episodic edema of the deeper layers of the skin or of the mucosa of the gastrointestinal tract. Although angioedema may affect any part of the body, the skin and gastrointestinal tract are involved most commonly by far. Episodic abdominal pain arising from angioedema affecting any intra-abdominal organ may occur without skin angioedema; therefore, angioedema must be included in the differential diagnosis of intermittent, unexplained abdominal pain. Angioedema is caused by extravasation of plasma in the affected areas, which at times is accompanied by nonspecific, minimal cellular infiltrate. The most commonly identified causes of angioedema are medications, allergens, and physical agents, but most angioedema is idiopathic. Rare forms of angioedema associated with either hereditary or acquired faulty activation of the complement and kallikrein-kinin systems have been extensively described. Taking a comprehensive personal and family history, performing a physical examination, and compulsively monitoring the response to therapy are the most rewarding and cost-effective diagnostic and treatment tools. Diligent and knowledgeable follow-up by the attending physician spares patients costly and unnecessary tests as well as harmful treatment. The most effective treatment depends on the identification of the causative mechanism and--especially when the mechanism is not identified--on the clinician's knowledge and experience with innovative therapeutic regimens.

Entities:  

Mesh:

Year:  2002        PMID: 12221866     DOI: 10.1385/CRIAI:23:2:217

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  55 in total

1.  Local bradykinin generation in hereditary angioedema.

Authors:  J Nussberger; M Cugno; M Cicardi; A Agostoni
Journal:  J Allergy Clin Immunol       Date:  1999-12       Impact factor: 10.793

Review 2.  C1 inhibitor deficiency: molecular and immunologic basis of hereditary and acquired angioedema.

Authors:  Z N Oltvai; E C Wong; J P Atkinson; K S Tung
Journal:  Lab Invest       Date:  1991-10       Impact factor: 5.662

Review 3.  C1 inhibitor and hereditary angioneurotic edema.

Authors:  A E Davis
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

4.  Detection of C1 inhibitor mutations in patients with hereditary angioedema.

Authors:  B L Zuraw; J Herschbach
Journal:  J Allergy Clin Immunol       Date:  2000-03       Impact factor: 10.793

Review 5.  Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology.

Authors:  Z H Israili; W D Hall
Journal:  Ann Intern Med       Date:  1992-08-01       Impact factor: 25.391

6.  Complement metabolism in man: hypercatabolism of the fourth (C4) and third (C3) components in patients with renal allograft rejection and hereditary, angioedema (HAE).

Authors:  C B Carpenter; S Ruddy; I H Shehadeh; H J Müller-Eberhard; J P Merrill; K F Austen
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

7.  Why do patients develop reactions to streptokinase?

Authors:  M Lynch; B L Pentecost; W A Littler; R A Stockley
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

8.  Angioneurotic oedema in the elderly.

Authors:  R P Brettle; R E Dunmow; L A Milne; P L Yap
Journal:  Scott Med J       Date:  1982-10       Impact factor: 0.729

9.  The metabolism of C1 inhibitor and C1q in patients with acquired C1-inhibitor deficiency.

Authors:  J Melamed; C A Alper; M Cicardi; F S Rosen
Journal:  J Allergy Clin Immunol       Date:  1986-02       Impact factor: 10.793

Review 10.  Angioedema with acquired deficiency of the C1 inhibitor: a constellation of syndromes.

Authors:  E Frigas
Journal:  Mayo Clin Proc       Date:  1989-10       Impact factor: 7.616

View more
  7 in total

Review 1.  Life-threatening angioedema in a patient with systemic lupus.

Authors:  Chao-Hsien Ko; Jennifer Ng; Sunil Kumar; Miriam Hurst
Journal:  Clin Rheumatol       Date:  2006-03-18       Impact factor: 2.980

Review 2.  Pediatric angioedema.

Authors:  Anita Krishnamurthy; Stanley M Naguwa; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

Review 3.  Angioedema with normal laboratory values: the next step.

Authors:  Janelle Sher; Mark Davis-Lorton
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

4.  Refractory Angioedema in a Patient with Systemic Lupus Erythematosus.

Authors:  Zahra Habibagahi; Jamshid Ruzbeh; Vahide Yarmohammadi; Malihe Kamali; Mohammad Hassan Rastegar
Journal:  Iran J Med Sci       Date:  2015-07

5.  Examination of genetic variants involved in generation and biodisposition of kinins in patients with angioedema.

Authors:  Jonathan Levy; Georges-Etienne Rivard; Eric Wagner; Don Beezhold; Noam Berlin; Li Fan; Zhao Zhang; Gordon L Sussman
Journal:  Allergy Asthma Clin Immunol       Date:  2014-12-12       Impact factor: 3.406

6.  Radiologic manifestations of angioedema.

Authors:  Kousei Ishigami; Sarah L Averill; Janet H Pollard; Joshua M McDonald; Yutaka Sato
Journal:  Insights Imaging       Date:  2014-05-03

7.  Angioedema without wheals: a clinical update.

Authors:  Okan Gülbahar
Journal:  Balkan Med J       Date:  2021-03       Impact factor: 2.021

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.